INTRODUCTION {#SEC1}
============

Regulated control of gene expression is a key feature of living cells. Classical examples include the *Escherichia coli lactose, galactose* and *tryptophan* operons ([@B1]). These operons are regulated by genetic 'off' or 'on' switches that prevent or enhance RNA polymerase access to the gene promoter, respectively. Regulatory control typically does not involve changing the concentration of regulatory proteins, but rather changing concentrations of small molecules that induce allosteric changes in these regulatory proteins. We are interested in engineering new gene regulatory switches in bacteria based on natural principles.

DNA looping is exploited as a fundamental principle in bacterial gene repression ([@B4]). DNA looping represses transcription initiation by at least two mechanisms. First, for bidentate repressor proteins like Lac repressor (LacI), protein saturation of an operator DNA sequence overlapping the RNA polymerase binding site can be increased by increasing the total local repressor concentration by contributions from repressors looping from a distant site ([@B5],[@B11],[@B13],[@B14]) compare Figure [1A and B](#F1){ref-type="fig"}). Second, trapping of a promoter within a strained DNA loop may be intrinsically repressive ([@B15]). While small molecule-induced allosteric affects in natural gene control switches typically alter the affinity of regulatory proteins for DNA (Figure [1C](#F1){ref-type="fig"}), here we explore switches where it is protein dimerization that is regulated by the small molecule (Figure [1D](#F1){ref-type="fig"}).

![Engineering DNA regulatory loops by analogy with natural bacterial repressors. (**A**) Constitutive 'off' switch. 'On' state (left) involves an unoccupied operator (grey box) at the promoter (broken arrow) allowing transcription of the downstream gene (filled arrow). 'Off\" state (right) involves a repressor protein (shown as a tetramer) binding at the operator, preventing promoter access by RNA polymerase. (**B**) Enhancing effective repressor concentration by DNA looping. Two unoccupied operators (grey boxes) flank the promoter to be regulated (left). The effective concentration of repressor (shown as a bidentate tetramer) at the proximal regulatory operator is the sum of contributions due to free, \[R\]~F~, and tethered, \[R\]~L~ (distal) repressors (right). (**C**) Inducible 'off' switch. 'Off' state (left) involves DNA looping anchored by a bidentate tetrameric repressor protein. 'On' state (right) is induced by tetramer destabilization into dimers, removing the contribution of tethered (distal) repressors. Residual repression is indicated by grey arrow. (**D**) Analogous inducible 'off' switch involving a designed TALED. A small molecule (small circles) decreases dimer stability. (**E**) TALED design. TALE protein (gray) with sequence-specific RVD cassettes highlighted and the amino acid sequence of one cassette illustrated (below) with specificity diresidue underlined. DD: dimerization domain. (**F**) Controlled TALED dimerization. TALE-FKBP(F36M) dimerization variant (left) is broken by FK506 (small circle). Polypeptide polarity is shown below. (**G**) TALE-FKBP(F36V) dimerization variant (right) is induced by AP20187.](gky047fig1){#F1}

We describe the design and testing of a regulated gene repression system controlled by dimerization of engineered sequence-specific Transcription Activator-Like Effector Dimers (TALEDs) expressed in living bacteria (Figure [1D](#F1){ref-type="fig"}). Transcription Activator-Like Effectors (TALEs) are remarkable protein products of plant pathogenic bacteria ([@B19]). Bacterial injection of these proteins into hosts is believed to foster infection through transcriptional activation of host genes. TALEs are composed of repeats of 34-amino acid domains carrying a repeat variable diresidue (RVD) encoding specificity for a target base pair. TALE proteins engage the DNA major groove, forming a right-handed protein spiral that binds at a specific DNA target sequence ([@B20],[@B21]), bringing a C-terminal transcription activation domain to the protein binding site in chromatin. TALE proteins have previously been fused to nucleases ('TALENs') for genetic engineering. Here we replace the TALE activation domain with a dimerization domain \[Figure [1E](#F1){ref-type="fig"}; ([@B19],[@B22])\]. In the present work we create new gene control switches in living bacteria by implementing TALEDs to mimic features of the natural *lac, gal* and *trp* gene control systems of *E. coli*. In particular, we borrow from the *gal* operon switch the concept that repression can be partly dependent on repressor protein dimerization.

MATERIALS AND METHODS {#SEC2}
=====================

DNA looping reporter constructs {#SEC2-1}
-------------------------------

DNA looping constructs ([Supplemental Table S1](#sup1){ref-type="supplementary-material"}) were based on plasmid pJ992 ([@B23]), created by modifications of pFW11-null ([@B24],[@B25]). See [supplemental methods](#sup1){ref-type="supplementary-material"} for full details.

TALE-FKBP protein expression {#SEC2-2}
----------------------------

Assembly and cloning of genes encoding TALEs has been facilitated by semi-automated methods ([@B26]). TALE-FKBP protein expression plasmids were created using modified versions of pJ1034 (low expression promoter) and pJ1035 (moderate expression promoter) ([@B25]). Plasmid pJ1035 contains the bacterial UV5 promoter with complete --10 and --35 boxes. The low expression plasmid pJ1034 contains the --10 box of the UV5 promoter with a non-ideal --35 box ([@B24]). See [supplemental methods](#sup1){ref-type="supplementary-material"} for full details.

*E. coli* β-galactosidase reporter assay {#SEC2-3}
----------------------------------------

LacZ expression was measured using a liquid β-galactosidase colorimetric enzyme assay ([@B27]). Repression quantitated in terms of repression ratio (RR): $$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*}{\rm RR} = \frac{{{U_{ - {\rm TALE} - {\rm FKBP}}}}}{{{U_{ + {\rm TALE} - {\rm FKBP}}}}}\end{equation*}\end{document}$$with the contribution to the repression ratio due to free repressor defined as RR~F~: $$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*}{{\rm RR}_{\rm F}} = {\left[ {\frac{{{U_{ - {\rm TALE} - {\rm FKBP}}}}}{{{U_{ + {\rm TALE} - {\rm FKBP}}}}}} \right]_{{\rm single}\ {\rm operator}}}\end{equation*}\end{document}$$the overall contributions to the repression ratio due to free repressor and DNA looping defined as RR~T~: $$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*}{{\rm RR}_{\rm T}} = {\left[ {\frac{{{U_{ - {\rm TALE} - {\rm FKBP}}}}}{{{U_{ + {\rm TALE} - {\rm FKBP}}}}}} \right]_{{\rm two}\ {\rm operators}}}\end{equation*}\end{document}$$and the contributions to the repression ratio due to DNA looping defined as RR~L~: $$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*}{{\rm RR}_{\rm L}} = \frac{{{{\rm RR}_{\rm T}}}}{{{{\rm RR}_{\rm F}}}}\end{equation*}\end{document}$$

See [supplemental methods](#sup1){ref-type="supplementary-material"} for full details.

Chemically induced dimerization of FKBP(F36V) variants {#SEC2-4}
------------------------------------------------------

Bacterial stains containing TALE-FKBP(F36V) variants were subcultured in the presence or absence of 1 μM dimerizing agent, AP20187 (Clontech), dissolved in methanol, followed by standard β-galactosidase assay. See [supplemental methods](#sup1){ref-type="supplementary-material"} for full details.

Chemical disruption of FKBP(F36M) variant dimerization {#SEC2-5}
------------------------------------------------------

Bacterial strains containing the TALE-FKBP expression plasmids pJ2307 (low protein expression) or pJ2309 (moderate protein expression) were grown in LB medium containing ampicillin. For reporter assay, ∼1.2 × 10^5^ bacterial cells were subcultured into 1.1 ml LB medium in the presence or absence of 3 μg/ml PMBN (Sigma). Also included at the time of subculture was dimer disruptor FK506 (Sigma), dissolved in DMSO to yield either 1 or 5 μM final concentration. See [supplemental methods](#sup1){ref-type="supplementary-material"} for full details.

RESULTS {#SEC3}
=======

TALED design {#SEC3-1}
------------

Designed TALEDs (Figure [1E](#F1){ref-type="fig"} and [Supplemental Figure S1](#sup1){ref-type="supplementary-material"}) were created by modification of a semi-automated method where clusters of modules with proper RVDs are encoded in DNA segments assembled by a Golden Gate procedure ([@B26]). In the original assembly system, RVDs are cloned into a plasmid with a C-terminal nuclease in place of the natural transcriptional activation domain. For production of TALEDs, the nuclease domain was replaced with various FKBP modules to facilitate dimerization. Fusion to a C-terminal FKBP(F36M) mutant domain allows constitutive dimerization (Figure [1F](#F1){ref-type="fig"}) that can be disrupted by small molecule FK506. FKBP(F36M) dimer affinity has been reported to be 30 μM *in vitro* ([@B28]). In contrast, fusion to a C-terminal FKBP(F36V) domain creates monomers whose homodimerization depends on the additional of a small molecule chemical dimerizer such as AP20187 (Figure [1G](#F1){ref-type="fig"}). In this case, dimer affinity has been reported to be in the nM range *in vitro* ([@B29]). Details are provided in [Supplemental Figure S1](#sup1){ref-type="supplementary-material"}.

*lac* looping model systems {#SEC3-2}
---------------------------

We and others have been studying engineered repression by DNA looping using elements of the natural *E. coli lac* operon ([@B17],[@B18],[@B23],[@B30]). To create an *in vivo* model for emulation using designed TALEDs, we assembled components of the *lac* control switch and analyzed quantitatively their behavior. This design is different from our previous published experiments because gene induction is accomplished by elimination of functional LacI rather than by addition of IPTG inducer. This scheme allows the results to be directly compared to an analogous system where TALEDs substitute for LacI. In one series (Figure [2A](#F2){ref-type="fig"}), a promoter-proximal pseudo-palindromic operator (O~2~) controls RNA polymerase access to the promoter, but is recognized weakly by LacI, while a palindromic operator that strongly binds LacI (O~sym~) is placed at four distances (70.5, 72.5, 75.5, 77.5 bp) upstream. Design details are shown in [Supplemental Figure S2A](#sup1){ref-type="supplementary-material"}. Resulting measurements of DNA repression *in vivo* are shown in Figure [2B](#F2){ref-type="fig"} and interpreted in Figure [2C](#F2){ref-type="fig"}. The repression ratio (RR; see methods) is defined as the level of expression of the *lacZ* reporter gene in the absence of any functional LacI (full 'on' state), divided by the corresponding level of *lacZ* expression when LacI is expressed at normal physiological levels (full 'off' state). As shown in Figure [2C](#F2){ref-type="fig"}, repression attributable to *free* repressor binding at O~2~ (RR~F~) has a value of 3, while increased local repressor concentration due to *looping* from O~sym~ gives RR~L~ as high as 43, increasing repression by a factor of as much as 14, for a *total* RR~T~ of up to 129. For comparison we also studied a *lac* looping switch where both proximal and distal palindromic O~sym~ operators bind LacI strongly (Figure [2D](#F2){ref-type="fig"} and [Supplemental Figure S2B](#sup1){ref-type="supplementary-material"}). Here, repression is much more complete and is dominated by the strong binding of free repressor at the proximal operator. Nonetheless, increasing local repressor concentration by DNA looping still contributes a factor of up to 5.4 to overall repression (Figure [2E](#F2){ref-type="fig"} and [F](#F2){ref-type="fig"}). Thus, these model systems illustrate that optimal operator spacing of natural components of the *lac* control switch allow DNA looping contributions to repression (RR~L~) in the range of 5--40 ([Supplemental Table S2](#sup1){ref-type="supplementary-material"}).

![DNA repression looping paradigm: Tetrameric LacI repression loop. (**A**) Strong distal O~sym~ operator and weak proximal O~2~ operator flanking test promoter. (**B**) Measured repression ratios (RR) comparing repression by a single proximal O~2~ operator with loops of four lengths between distal O~sym~ and proximal O~2~. (**C**) Interpretation of results showing respective contributions of free (RR~F~) and tethered (RR~L~) repressors, whose product is RR~T~. Here, the contribution of distal tethered repressor to effective repressor concentration at the proximal site is more than 14-fold higher than for free repressor. (**D**--**F**) Comparable data for loops involving two strong O~sym~ operators. Data for all experiments reflect the mean of at least six determinations with standard deviation indicated.](gky047fig2){#F2}

TALED-based *lac* repression in vivo {#SEC3-3}
------------------------------------

To test whether DNA looping by designed TALEDs could lead to an enhancement of gene repression comparable to that caused by looping by LacI, we designed a TALE protein against a 15-bp sequence within the O~sym~ operators present in the test construct (Figure [3A](#F3){ref-type="fig"}). Operator symmetry dictates that this TALE protein can bind in either of two orientations (Figure [3B](#F3){ref-type="fig"}), unavoidably creating four potential competing DNA repression loops with different geometries ([Supplemental Figure S3](#sup1){ref-type="supplementary-material"}). Four operator spacing constructs and a control bearing only a proximal operator were tested in living *E. coli* cells after expression of the O~sym~-specific TALED with FKBP(F36M) constitutive dimerization domain from a moderate promoter. The results (Figure [3C](#F3){ref-type="fig"} and [D](#F3){ref-type="fig"}) demonstrate that enhancement of repression due to DNA looping anchored by the TALED (RR~L~ ∼ 4.4) is comparable to repression enhancement for LacI in this system (compare Figures [2F](#F2){ref-type="fig"} and [3D](#F3){ref-type="fig"}). This is true despite the potential for four competing DNA--protein loops of different geometries for each operator spacing. Importantly, significant enhancement of repression is not observed for TALE fusions involving FKBP(F36V) domains, which do not dimerize (Figure [3E](#F3){ref-type="fig"} and [F](#F3){ref-type="fig"}). Qualitatively similar results were obtained when TALEDs were expressed at lower levels ([Supplemental Table S3](#sup1){ref-type="supplementary-material"}). Importantly, we also showed that TALED binding to the distal O~sym~ operator at various distances from a promoter lacking a proximal operator had no effect on gene expression ([Supplemental Table S4](#sup1){ref-type="supplementary-material"}). This result confirms that repression enhancement is due to DNA looping, as designed. Together, these results demonstrate for the first time engineered *in vivo* transcriptional regulation by DNA looping anchored by a designed TALED.

![A designed TALED represses gene expression by DNA looping. (**A**) Test system involving O~sym~ operators at four spacings. (**B**) Designed TALE protein binding sites (gray) and orientations within each symmetrical O~sym~ operator. (**C**) Measured repression ratios (RR) comparing repression by a single proximal O~sym~ operator with DNA loops of four lengths between distal O~sym~ and proximal O~sym~. (**D**) Interpretation of results showing respective contributions of free (RR~F~) and tethered (RR~L~) TALEs, whose product is RR~T~. Here TALED-induced DNA looping enhances repression by 4.4-fold. (**E** and **F**) Comparable data for experiments with TALE monomers.](gky047fig3){#F3}

Tuning TALED-controlled gene repression {#SEC3-4}
---------------------------------------

As shown in Figure [2](#F2){ref-type="fig"}, quantitative enhancement of gene repression by DNA looping with LacI is a function of operator affinity and loop geometry. To test this in the context of TALEDs, we designed a series of variant operators and tested repression from these operators when they were placed alone in the proximal position in cells expressing the O~sym~-specific TALED fused to FKBP(F36M). Unlike recognition of palindromic O~sym~, most of the variant operators are asymmetric and are recognized in only a single orientation. TALED binding to these isolated variant operators indeed led to weaker repression, as designed ([Supplemental Figure S4](#sup1){ref-type="supplementary-material"}).

We then tested TALED-mediated enhancement of gene repression by DNA looping between distal O~sym~ and either proximal O~B~ (Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}) or proximal O~invB~ (Figure [4C](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}) operators. These configurations involve weaker proximal operators and probably two (rather than four) competing DNA loops ([Supplemental Figure S3](#sup1){ref-type="supplementary-material"}). Maximal RR~L~ values ranged from 3.4--5.6 in these cases. Qualitatively similar results were obtained when TALEDs were expressed at lower levels ([Supplemental Table S5](#sup1){ref-type="supplementary-material"}).

![Tuning operator affinity and TALED repression looping. Data (**A**, **C**) and interpretation (**B, D**) for gene repression by designed TALED loops between strong (O~sym~) distal operators and weak O~B~ (A, B) and O~invB~ (C, D) operators.](gky047fig4){#F4}

Regulation of gene repression by TALEDs: co-repression or induction by small molecules {#SEC3-5}
--------------------------------------------------------------------------------------

A hallmark of natural gene regulation is triggering by small molecules that increase or decrease repression of gene transcription. We sought to mimic this regulation with TALEDs whose FKBP domain *dimerization* is sensitive to small molecules. We began with a model of co-repression where partial gene repression by an TALE protein monomer bearing FKBP(F36V) binding at a weak O~B~ proximal operator (Figure [5A](#F5){ref-type="fig"} and [B](#F5){ref-type="fig"}) yields an RR~F~ value of ∼23 and a very low RR~L~ value of ∼1.5. This anticipated result is consistent with the lack of FKBP(F36V) dimerization in the absence of a chemical dimerizer (Figure [1G](#F1){ref-type="fig"}). Addition of the cell-permeable chemical dimerizer AP20187 at a concentration found to be effective in *E. coli* ([Supplemental Figure S5](#sup1){ref-type="supplementary-material"}) revealed engineered co-repression as designed (Figure [5C](#F5){ref-type="fig"} and [D](#F5){ref-type="fig"}). The RR~L~ value in the presence of co-repressor was ∼2.3, raising overall repression (RR~T~) to ∼50 for the optimal operator spacing. Qualitatively similar results were obtained when TALEDs were expressed at lower levels ([Supplemental Table S6](#sup1){ref-type="supplementary-material"}). We cannot conclusively explain the difference between the RR~L~ value of ∼2.3 obtained for chemical dimerization (Figure [5D](#F5){ref-type="fig"}) vs. the value of ∼4.4 obtained for protein-protein dimerization (Figure [3D](#F3){ref-type="fig"}). Based on the reported affinity of the chemical dimerizer, it might have been anticipated that repression by chemical dimerization might be tighter. It seems likely that this discrepancy is due to two non-optimal features of the chemical dimerizer AP20187. These are (i) intracellular AP20187 dose may not be optimal ([Supplemental Figure S5](#sup1){ref-type="supplementary-material"}) and (ii) there will always be a competition between one dimerizer molecule bridging two proteins (desired) and one dimerizer molecule capping each protein (undesired).

![Chemically-induced dimerization triggers TALED repression by DNA looping. Data (**A, C**) and interpretation (**B, D**) for gene repression involving designed TALE-FKBP(F36V) repressors without (A, B) or with (C, D) chemically-induced dimerization by 1 μM AP20187.](gky047fig5){#F5}

We likewise sought to model gene induction with a small molecule by artificially triggering disruption of TALED dimerization in *E. coli*. In this case, *E. coli* cells carrying the previously-studied combination of distal O~sym~ and proximal O~invB~ operators and expressing a dimerizing TALED fusion to FKBP(F36M) (Figure [4C](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}) were tested in the absence or presence of the permeabilizing agent polymyxin B nonapeptide \[PMBN; ([@B33],[@B34])\]. PMBN concentration was optimized by measuring uptake of small molecule antibiotics and FK506 ([Supplemental Figure S6](#sup1){ref-type="supplementary-material"}). Addition of permeabilizer preserves DNA looping and gene repression (Figure [6A](#F6){ref-type="fig"} and [B](#F6){ref-type="fig"}). Strong RR~L~ values of ∼5.6--6.6 are observed for an overall RR~T~ of ∼39--53. In contrast, with addition of the small molecule FK506 (1 or 5 μM), TALED dimerization is inhibited, and derepression is observed (RR~L~ value ∼1.8) as intended (Figure [6C](#F6){ref-type="fig"} and [D](#F6){ref-type="fig"}). Qualitatively similar results were obtained when TALEDs were expressed at lower levels ([Supplemental Table S7](#sup1){ref-type="supplementary-material"}).

![Chemically-induced TALED disruption of dimerization induces gene expression by DNA un-looping. Data (**A, C**) and interpretation (**B, D**) for gene repression involving designed TALE-FKBP(F36M) repressors without (A, B) or with (C, D) chemically-induced disruption of dimerization by FK506.](gky047fig6){#F6}

DISCUSSION {#SEC4}
==========

Our focus in this work has been engineered approaches to artificial control of transcription initiation in *E. coli*. We based our strategy on the DNA looping paradigm common in natural gene control. Here we engineer homodimeric TALEDs for this purpose, demonstrating that DNA looping increases promoter repression to extents comparable to switches involving LacI protein. Exploiting dimerization domains based on FKBP variants, we further show how small molecules can act as co-repressors or inducers in these engineered switches by regulating TALE protein dimerization. This approach is distinct from two elegant prior *in vitro* studies that did not explore gene control in living cells. Gowetski *et al.* engineered DNA loops through designed coiled-coil peptides ([@B32]). Praetorius and Dietz have recently shown *in vitro* assembly of complex duplex DNA shapes by DNA looping anchored by designed constitutive dimeric TALE proteins ([@B35]). In contrast, our work implements TALEDs in living cells with controlled TALE dimerization regulating gene expression.

In the present study, we have intentionally limited ourselves to adapting cis regulatory elements from the *E. coli lac* operon where much is known about DNA looping between natural and artificial sequence variants of the palindromic *lac* operator sequence. Building *lac* operator-specific TALEDs has the advantage that it allows the engineered system to be directly compared to *lac* regulation by LacI. On the other hand, the palindromic nature of natural *lac* operators complicates designed DNA loops anchored by asymmetric TALEDs because multiple competing loop geometries always result. Our data show that this complexity does not prevent the desired functions, but it typically obscures the expected sinusoidal dependence of repression on distance between operators (phasing). We thus attribute the absence of sinusoidal repression dependence on operator phasing to the presence of competing loops (where one loop need not dominate), together with the flexibility of the TALED proteins themselves. An additional complication to interpretation of preferred operator phasings is that the FKBP dimer interface and protein orientations for the FKBP F36M dimer are likely to differ from FKBP F36V after chemical dimerization ([@B28]). Nonetheless, for general application the profound advantage of designed sequence-specific TALE-based protein domains will easily permit specification of unique DNA loops by selecting non-palindromic operator sequences.

Future implementations of the TALED strategy described here can be envisioned to exploit the formation of heterodimeric repressor proteins. When combined with selective heterodimer stabilization or destabilization by available small molecules, such approaches will further generalize microbial applications. Likewise, further development of small molecule triggers to which bacterial cells are highly permeable will further advance application.

It is important to emphasize that regulation of our engineered switches is achieved by controlling the probability of repressor protein dimerization rather than the allosteric control of DNA binding affinity that is pervasive in biological systems. Thus, controlled elimination of DNA looping reduces, but does not eliminate, TALE protein monomer binding at the proximal operator. Overcoming this resulting weak residual repression would involve devising TALE proteins that mimic natural repressors whose DNA affinity can be allosterically controlled by small molecules.

In summary, the present work engineers control of bacterial gene expression by mimicry of natural DNA looping mechanisms using designed repressors whose dimerization can be controlled. It is plausible that similar approaches can be implemented in the context of transcription initiation from eukaryotic promoters to create regulated transcriptional repression by TALED-directed looping of chromatin via arbitrary targeted sequences. Such approaches would greatly extend the previously-recognized principle of eukaryotic gene regulation by DNA looping ([@B36],[@B37]).
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